<DOC>
	<DOCNO>NCT00191919</DOCNO>
	<brief_summary>To determine efficacy Duloxetine vs. placebo pain determine change Brief Pain Inventory ( BPI ) baseline 8 week treatment</brief_summary>
	<brief_title>A Randomized Double Blind Study Evaluating Duloxetine Outpatients With MDD Pain</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Major Depressive Disorder accord DSMIV criterion least one previous depressive episode patient 's medical history Painful physical symptom measure Brief Pain InventoryShort Form Any anxiety disorder primary diagnosis within past 6 month ( include panic disorder , OCD , PTSD , generalize anxiety disorder social phobia ) Any diagnosis bipolar disorder , schizophrenia , psychotic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2007</verification_date>
</DOC>